Finanztrends
Deine Einschätzung
Was spricht für und gegen Genetic Technologies Ltd. in den nächsten Jahren?
Pro
?
L*********** I********** f** d** n******* J****
?
U****************
?
A****************
Kontra
?
M****
?
M************
?
W******* i* V********
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Genetic Technologies Ltd. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Genetic Technologies Ltd. | - | - | - | - | - | - | - |
| TALI Digital Ltd. | - | 0,00 % | -99,44 % | 0,00 % | -98,53 % | 0,00 % | -96,97 % |
| Invion Ltd | 0,00 % | 0,00 % | 5,00 % | -47,50 % | -47,50 % | 2000,00 % | 180,00 % |
| Alterity Therapeutics Ltd. ADR | -3,23 % | -8,63 % | -20,00 % | -4,13 % | 45,16 % | -4,13 % | -66,67 % |
Kommentare
News
Black Diamond Therapeutics Touts Silevertinib Lung Cancer Data, Eyes FDA Path
Key Points
- Interested in Black Diamond Therapeutics, Inc.? Here are five stocks we like better.
- Silevertinib showed encouraging Phase 2 lung cancer data, including a 60% objective response
Pelthos Therapeutics Q1 Earnings Call Highlights
Pelthos Therapeutics (NYSEAMERICAN:PTHS) reported higher first-quarter revenue as prescriptions for its lead product, ZELSUVMI, continued to grow in the treatment’s third full quarter since launch